Advances in Osteoclast Differentiation and Function

E-ISSN： 1875-5917|5|3|347-355

ISSN： 1568-0088

Source： Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol.5, Iss.3, 2005-09, pp. : 347-355

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation

By Baron R. Tsouderos Y.

European Journal of Pharmacology, Vol. 450, Iss. 1, 2002-08 ,pp. : 11-17

Elsevier

Access to resources Recommend Favorite

Therapeutic targeting of osteoclast function and pathways

By Broadhead Matthew L Clark Jonathan CM Dass Crispin R Choong Peter FM Myers Damian E

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 2, 2011-02 ,pp. : 169-181

Informa Healthcare

Access to resources Recommend Favorite

Osteoclast differentiation inhibitors: a patent review (2008 – 2012)

By Kim Seong Hwan Moon Seong-Hee

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 12, 2013-12 ,pp. : 1591-1610

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of osteoclast formation by 3-methylcholanthrene, a ligand for arylhydrocarbon receptor: suppression of osteoclast differentiation factor in osteogenic cells

By Naruse M. Otsuka E. Naruse M. Ishihara Y. Miyagawa-Tomita S. Hagiwara H.

Biochemical Pharmacology, Vol. 67, Iss. 1, 2004-01 ,pp. : 119-127

Elsevier

Access to resources Recommend Favorite

Hyperglycemia enhances function and differentiation of adult rat cardiac fibroblasts

By Shamhart Patricia E. Luther Daniel J. Adapala Ravi K. Bryant Jennifer E. Petersen Kyle A. Meszaros J. Gary Thodeti Charles K

Canadian Journal of Physiology and Pharmacology, Vol. 92, Iss. 7, 2014-01 ,pp. : 598-604

NRC Research Press

Access to resources Recommend Favorite